APA (7th ed.) Citation

W, S., B, Y., HJ, K., D, S., I, J., J, R., . . . EJ, L. (2026). Distinct remission immune architectures under rituximab and azathioprine in AQP4-IgG-positive neuromyelitis optica spectrum disorder. Frontiers in immunology, 17, 1834992. https://doi.org/10.3389/fimmu.2026.1834992

Chicago Style (17th ed.) Citation

W, Shin, et al. "Distinct Remission Immune Architectures Under Rituximab and Azathioprine in AQP4-IgG-positive Neuromyelitis Optica Spectrum Disorder." Frontiers in Immunology 17 (2026): 1834992. https://doi.org/10.3389/fimmu.2026.1834992.

MLA (9th ed.) Citation

W, Shin, et al. "Distinct Remission Immune Architectures Under Rituximab and Azathioprine in AQP4-IgG-positive Neuromyelitis Optica Spectrum Disorder." Frontiers in Immunology, vol. 17, 2026, p. 1834992, https://doi.org/10.3389/fimmu.2026.1834992.